Xie Cuiling, Zheng QingXiang, Jiang Xiumin, Liao Yanping, Gao Xiaoxia, Zhu Yu, Li Jianing, Liu Rulin
School of Nursing, Fujian Medical University, Fuzhou, China.
Nursing Department, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Front Nutr. 2024 Dec 12;11:1449000. doi: 10.3389/fnut.2024.1449000. eCollection 2024.
Cholesterol is essential for pregnant women to maintain maternal health and fetal support development. This study aimed to assess the cholesterol intake of women with gestational diabetes mellitus (GDM) during the second and third trimesters of pregnancy and to explore its effects on blood glucose and pregnancy outcomes.
This prospective cohort study collected dietary data using a food frequency questionnaire (FFQ) administered during the 24-30 gestational weeks (first survey) and the 34-42 gestational weeks (second survey). Blood glucose parameters and pregnancy outcomes were obtained from electronic medical records. Participants were divided into two groups according to the median cholesterol intake: low and high cholesterol intake groups.
GDM women generally consumed high levels of cholesterol during pregnancy, with intake increasing in the third trimester compared to the second trimester. Compared to women with high cholesterol intake, GDM women with low cholesterol intake had a higher risk of abnormal hemoglobin A1C (HbA1C) during the second trimester [OR 26.014 (95% CI 2.616-258.727)] and the third trimester [OR 2.773 (95% CI 1.028-7.482)], as well as abnormal fasting blood glucose during the third trimester [OR 2.907 (95% CI 1.011-8.360)]. Furthermore, in the second trimester, GDM women with high cholesterol intake had higher risks of macrosomia [OR 23.195 (95% CI 2.650-203.024)] and large for gestational age (LGA) [OR 3.253 (95% CI 1.062-9.965)] but lower risks of small for gestational age (SGA) [OR 0.271 (95% CI 0.074-0.986)] compared to those with low cholesterol intake. However, in the third trimester, GDM women with high cholesterol intake had lower risks of macrosomia [OR 0.023 (95% CI 0.001-0.436)] and LGA [OR 0.199 (95% CI 0.042-0.949)].
Cholesterol intake among GDM women during pregnancy was associated with blood glucose control and significantly influenced the risks of macrosomia, LGA, and SGA. However, LGA and SGA were also influenced by pre-pregnancy BMI, indicating cholesterol intake was one of multiple contributing factors. Limiting cholesterol intake may help GDM women better manage blood glucose levels and mitigate adverse pregnancy outcomes.
胆固醇对于孕妇维持母体健康和支持胎儿发育至关重要。本研究旨在评估妊娠糖尿病(GDM)女性在妊娠中期和晚期的胆固醇摄入量,并探讨其对血糖和妊娠结局的影响。
这项前瞻性队列研究使用在妊娠24 - 30周(首次调查)和34 - 42周(第二次调查)期间发放的食物频率问卷(FFQ)收集饮食数据。血糖参数和妊娠结局数据来自电子病历。参与者根据胆固醇摄入量中位数分为两组:低胆固醇摄入量组和高胆固醇摄入量组。
GDM女性在孕期通常摄入较高水平的胆固醇,与妊娠中期相比,妊娠晚期摄入量增加。与高胆固醇摄入量的女性相比,低胆固醇摄入量的GDM女性在妊娠中期[比值比(OR)26.014(95%置信区间[CI] 2.616 - 258.727)]和妊娠晚期[OR 2.773(95% CI 1.028 - 7.482)]出现糖化血红蛋白(HbA1C)异常的风险更高,在妊娠晚期空腹血糖异常的风险也更高[OR 2.907(95% CI 1.011 - 8.360)]。此外,在妊娠中期,高胆固醇摄入量的GDM女性出现巨大儿[OR 23.195(95% CI 2.650 - 203.024)]和大于胎龄儿(LGA)[OR 3.253(95% CI 1.062 - 9.965)]的风险更高,但小于胎龄儿(SGA)的风险更低[OR 0.271(95% CI 0.074 - 0.986)],与低胆固醇摄入量的女性相比。然而,在妊娠晚期,高胆固醇摄入量的GDM女性出现巨大儿[OR 0.023(95% CI 0.001 - 0.436)]和LGA[OR 0.199(95% CI 0.042 - 0.949)]的风险更低。
GDM女性孕期的胆固醇摄入量与血糖控制相关,并显著影响巨大儿、LGA和SGA的风险。然而,LGA和SGA也受到孕前体重指数的影响,表明胆固醇摄入量是多种影响因素之一。限制胆固醇摄入量可能有助于GDM女性更好地控制血糖水平并减轻不良妊娠结局。